Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-25-013970
Filing Date
2025-04-15
Accepted
2025-04-15 16:35:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20042262x772_defa14a.htm DEFA14A 14937
2 ny20042262x772_nc01.jpg GRAPHIC 120602
3 ny20042262x772_nc02.jpg GRAPHIC 80195
  Complete submission text file 0001140361-25-013970.txt   292909
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36728 | Film No.: 25840041
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)